Latest News
Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine
18 November 2010
Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for Cat Allergy T-cell Vaccine
Extended clinical portfolio now includes four mid-stage development programmes
30 September 2010
Circassia Out-licenses ToleroTrans Organ Transplant Anti-Rejection Technology to Oxford Immunotec
12 August 2010
Did you know?
The average bed could be home to up to 1.5 million house dust mites